Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 56% ± 19% | |
peripheral blood | 18 studies | 38% ± 11% | |
brain | 16 studies | 32% ± 24% | |
intestine | 13 studies | 50% ± 26% | |
liver | 10 studies | 38% ± 19% | |
kidney | 9 studies | 48% ± 17% | |
eye | 7 studies | 35% ± 18% | |
heart | 7 studies | 26% ± 10% | |
uterus | 6 studies | 63% ± 25% | |
pancreas | 5 studies | 67% ± 25% | |
bone marrow | 5 studies | 33% ± 12% | |
prostate | 5 studies | 56% ± 21% | |
placenta | 4 studies | 56% ± 21% | |
adipose | 4 studies | 48% ± 21% | |
skin | 4 studies | 52% ± 24% | |
breast | 4 studies | 57% ± 8% | |
ovary | 3 studies | 46% ± 12% | |
adrenal gland | 3 studies | 31% ± 11% | |
esophagus | 3 studies | 50% ± 13% | |
stomach | 3 studies | 30% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 24496.64 | 652 / 653 | 100% | 524.91 | 604 / 605 |
brain | 100% | 62858.92 | 2635 / 2642 | 100% | 1114.19 | 704 / 705 |
prostate | 100% | 27809.25 | 244 / 245 | 100% | 362.76 | 500 / 502 |
adrenal gland | 100% | 23458.97 | 258 / 258 | 99% | 403.73 | 228 / 230 |
stomach | 100% | 26250.17 | 359 / 359 | 99% | 477.18 | 283 / 286 |
ovary | 99% | 18964.72 | 178 / 180 | 100% | 515.65 | 430 / 430 |
intestine | 100% | 25710.75 | 964 / 966 | 99% | 442.32 | 522 / 527 |
esophagus | 100% | 29777.27 | 1442 / 1445 | 99% | 299.12 | 181 / 183 |
skin | 99% | 16128.09 | 1787 / 1809 | 99% | 372.47 | 466 / 472 |
bladder | 100% | 24393.76 | 21 / 21 | 96% | 349.55 | 486 / 504 |
pancreas | 97% | 13233.94 | 318 / 328 | 99% | 443.89 | 177 / 178 |
uterus | 100% | 22546.57 | 170 / 170 | 96% | 265.65 | 442 / 459 |
kidney | 96% | 15939.94 | 85 / 89 | 99% | 296.59 | 891 / 901 |
liver | 97% | 14657.56 | 219 / 226 | 97% | 242.08 | 394 / 406 |
lung | 99% | 20991.62 | 570 / 578 | 95% | 271.53 | 1100 / 1155 |
breast | 100% | 31712.21 | 459 / 459 | 92% | 292.92 | 1024 / 1118 |
adipose | 100% | 34724.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 307.28 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 279.16 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 183.59 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 107.24 | 1 / 1 |
blood vessel | 100% | 35463.87 | 1331 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 24159.91 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 99% | 25052.61 | 853 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 14976.14 | 749 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 70% | 10478.59 | 653 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060311 | Biological process | negative regulation of elastin catabolic process |
GO_0010711 | Biological process | negative regulation of collagen catabolic process |
GO_2000117 | Biological process | negative regulation of cysteine-type endopeptidase activity |
GO_0060313 | Biological process | negative regulation of blood vessel remodeling |
GO_0097435 | Biological process | supramolecular fiber organization |
GO_0045861 | Biological process | negative regulation of proteolysis |
GO_0010466 | Biological process | negative regulation of peptidase activity |
GO_0034103 | Biological process | regulation of tissue remodeling |
GO_0010716 | Biological process | negative regulation of extracellular matrix disassembly |
GO_0006952 | Biological process | defense response |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0031982 | Cellular component | vesicle |
GO_0004869 | Molecular function | cysteine-type endopeptidase inhibitor activity |
GO_0004866 | Molecular function | endopeptidase inhibitor activity |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0030414 | Molecular function | peptidase inhibitor activity |
GO_0002020 | Molecular function | protease binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CST3 |
Protein name | Cystatin-C (Cystatin-3) (Gamma-trace) (Neuroendocrine basic polypeptide) (Post-gamma-globulin) |
Synonyms | |
Description | FUNCTION: As an inhibitor of cysteine proteinases, this protein is thought to serve an important physiological role as a local regulator of this enzyme activity. |
Accessions | ENST00000398411.5 ENST00000376925.8 P01034 ENST00000398409.1 |